Visual Impairment Clinical Trials
2 recruiting trials for Visual Impairment. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Visual Impairment clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University of Edinburgh (1), The Hong Kong Polytechnic University (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Action video game training (behavioral, 1 trial), followed by Conventional physical training.
Track Visual Impairment trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Visual Frailty in Ageing
The goal of this observational study is to define visual frailty and refine monitoring for an ageing population. It involves piloting a visual frailty assessment tool in a cohort...
Glaucoma Rehabilitation With Action viDeo Games and Exercise - GRADE
Falls are one of the most serious public health concerns for seniors, with significant medical and economic consequences. This concern is even higher in patients with peripheral...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Visual Impairment, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Visual Impairment, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Visual Impairment, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.